Keywords
valsartan,diovan,valzan,arb (angiotensin ii receptor blocker),antihypertensive,cardiovascular drug,c24h29n5o3,molecular formula: c24h29n5o3,structural formula: valsartan,chemical structure,structural formula,carboxylic acid,tetrazole ring,amide bond,biphenyl group,phenyl rings,methyl group,pentanoic acid,angiotensin ii receptor antagonist,blood pressure reduction,heart failure treatment,hypertension,raas (renin-angiotensin-aldosterone system),angiotensin ii blockade,blood pressure regulation,cardiac function,vasodilation,specificity for the at1 receptor,oral bioavailability,reduces cardiovascular risk,does not inhibit ace or affect bradykinin,carbon,hydrogen,nitrogen,oxygen,single bonds,double bonds,aromatic bonds,cardiovascular pharmacology,heart failure,hypertension medication,arb therapy,cardioprotective agents,pharmaceutical chemistry,drug design,therapeutics,pharmacodynamics,pharmacokinetics,antihypertensive therapy,angiotensin ii receptor blocker,vasodilator,cardiovascular agents,blood pressure management,chronic heart failure,raas inhibitors,valsartan pharmacology,carbon,c,oxygen,o,hydrogen,h,nitrogen,n,single bond,double bond,structural formula,structural,formula,chemical compound,structural chemistry,bond,line bond,charge,proj-creative-abx-24q2
proj-creative-abx-24q2,proj-creative-abx-24q2-novartis,valsartan